Introduction {#s1}
============

Sepsis and the resulting multi-organ failure are still associated with high morbidity and mortality rates \[[@R01]\]. The management of patients with sepsis should begin in the emergency department (ED) in accordance with the international guidelines of the Surviving Sepsis Campaign \[[@R02]\]. Serial lactate concentration measurements are helpful in evaluating the progression of sepsis and can guide decision-making by clinicians.

Most clinicians use arterial blood samples to measure lactate levels. However, in the ED setting and especially in conscious patients, arterial puncture causes patient discomfort and also has a small risk of arterial injury or other complications, including thrombosis and ischemia \[[@R03]\]. As an alternative to arterial sampling, clinicians sometimes use repeated lactate measurements via peripheral or central veins when available, and peripheral venous lactate sampling has been used as part of routine blood testing in some cases \[[@R04], [@R05]\]. However, only a few studies have evaluated the role of venous blood lactate measurements as alternative to arterial blood sampling. The aim of this study is to evaluate the interchangeability of the arterial blood lactate with the peripheral venous lactate and the central venous lactate (CV-lactate) in patients with sepsis treated in the ED.

Materials and Methods {#s2}
=====================

This prospective study was conducted in the Emergency Department of the University Hospital of Patras, in Western Greece, between November 2017 and May 2018 and enrolled 31 patients. Inclusion criteria were age \> 18 years and diagnosis of sepsis of any origin confirmed by clinical examination, laboratory tests, radiographic findings (e.g. chest X-ray) or any other intervention performed in the ED.

Exclusion criteria were known liver or renal failure, and metformin use. The diagnosis of sepsis was established according to the recently published Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) definitions criteria \[[@R06]\]. All patients were assessed and treated in the resuscitation room of the ED in accordance with the initial resuscitation guidelines of the Surviving Sepsis Campaign \[[@R02]\].

A central line was inserted in patients with poor peripheral access and in patients who required support with continuous infusion of vasopressors for resuscitation purposes. Three separate blood samples were simultaneously obtained from central and peripheral veins and arterial sampling for lactate analysis. All blood samples were immediately analyzed in a point of care blood gas analyzer (Stat Profile pHOx Ultra TM/CCXTMLactate Membrane Kit, NOVA BIOMEDICAL, Waltham, MA, USA).

The study was conducted in compliance with the ethical standards of the responsible institution on human subjects and with the Helsinki Declaration. The study protocol was approved by the Institutional Review Board of the University Hospital. All patients (or their legal guardian) gave written informed consent before enrolling in the study. Data collected for the study were anonymized and stored in an encrypted electronic database. The medical team involved in the study included University of Patras faculty, resident physicians rotating through the ED and outside consultants.

Statistical analysis {#s2a}
--------------------

All patient data were anonymized, entered in a secure electronic database and stored in a secure, encrypted personal computer. Data were analyzed using the MedCalc Statistical Software version 18.11.6 (MedCalc Software bvba, Ostend, Belgium; <https://www.medcalc.org>; 2019). Normality of data distribution was assessed using the Kolgomorov-Smirnov test. Repeated measures analysis of variance (ANOVA) was used to compare lactate levels in arterial blood versus peripheral vein versus central vein samples, and paired *t*-test was used for *post hoc* analysis when indicated.

Correlation between lactate values from the three different locations was assessed using Pearson correlation. When correlations were significant, linear regression analysis was conducted in order to assess how well the values of one variable (on the X axis) can predict the values of the other variable (on the Y axis). Data are presented as mean ± standard deviation (SD) or as median (min, max) as appropriate. P \< 0.05 was considered statistically significant for all analysis. Bland-Altman plots were generated to evaluate agreement in lactate measurements between the three different sampling locations.

Results {#s3}
=======

In total, 31 patients were included in the study. Data were collected from 31 patients, 13 men and 18 women. Patient age was 75.1 ± 9.7 for men versus 79.1 ± 14 for women, and there were no significant differences between men and women. Lactate levels were measured in arterial blood in 26 patients, in central venous blood in 16 patients and in peripheral venous blood in 29 patients. As a result, we could compare and correlate arterial versus peripheral vein samples in 26 patients, but we had data from all three sources in only 13 patients.

Comparison between variables using repeated measures ANOVA showed that there was no significant difference between lactate levels in arterial (3.08 ± 1.56) versus peripheral venous (3.1 ± 1.78) versus central venous blood (3.22 ± 1.92, P \> 0.8, [Fig. 1](#F1){ref-type="fig"}).

![Box-plot diagrams comparing arterial versus central vein versus peripheral vein lactate levels. There are no significant differences between the three sample sites.](jocmr-11-629-g001){#F1}

There was very strong, highly significant correlation between arterial and peripheral venous lactate levels (Pearson's r = 0.880, P \< 0.0001), between arterial and central venous blood (Pearson's r = 0.898, P \< 0.0001) and between central and peripheral venous blood (Pearson's r = 0.941, P \< 0.0001). Results of correlation analysis for lactate concentrations in different samples are summarized in [Table 1](#T1){ref-type="table"}.

###### Correlations Between Arterial, Peripheral Vein and Ventral Vein Lactate Values

  Sites of lactate measurement        Arterial    Peripheral vein   Central vein
  ----------------------------------- ----------- ----------------- --------------
  Arterial                                                          
    Pearson correlation coefficient               0.880             0.898
    Significance level P                          \< 0.0001         \< 0.0001
    n                                             26                13
  Peripheral vein                                                   
    Pearson correlation coefficient   0.880                         0.941
    Significance level P              \< 0.0001                     \< 0.0001
    n                                 26                            16
  Central vein                                                      
    Pearson correlation coefficient   0.898       0.941             
    Significance level P              \< 0.0001   \< 0.0001         
    n                                 13          16                

Regression analysis showed that lactate concentration in peripheral vein blood is a strong, highly significant but imperfect predictor of lactate concentration in arterial blood (r = 0.88, P \< 0.001, [Fig. 2a](#F2){ref-type="fig"}) and in central venous blood (r = 0.94, P \< 0.001, [Fig. 2b](#F2){ref-type="fig"}). Regression analysis also showed that lactate concentration in central vein blood is a strong, highly significant but imperfect predictor of lactate concentration in arterial blood (r = 0.90, P \< 0.001, [Fig. 2c](#F2){ref-type="fig"}).

![Linear regression analysis: peripheral blood lactate is a strong, highly significant but imperfect predictor of arterial blood lactate (r = 0.88, P \< 0.001) (a), peripheral vein lactate is a strong, highly significant but imperfect predictor of central vein lactate (r = 0.94, P \< 0.001) (b), and central vein lactate is a strong, highly significant but imperfect predictor of arterial blood lactate (r = 0.90, P \< 0.001) (c).](jocmr-11-629-g002){#F2}

Bland-Altman plot analysis showed good agreement between lactate concentration in central vein and that in peripheral vein ([Fig. 3a](#F3){ref-type="fig"}), between lactate concentration in central vein and that in arterial blood ([Fig. 3b](#F3){ref-type="fig"}), and between lactate concentration in peripheral vein and that in arterial blood ([Fig. 3c](#F3){ref-type="fig"}).

![Bland-Altman plot shows good agreement between central vein lactate and peripheral vein lactate (a), between central vein lactate and arterial blood lactate (b) and between arterial blood lactate and peripheral vein lactate (c).](jocmr-11-629-g003){#F3}

Discussion {#s4}
==========

The sepsis syndrome has complex underlying pathophysiology with severe cellular and metabolic abnormalities leading to cellular metabolism imbalance resulting in increased lactate production \[[@R07]\]. When tissue hypoxia exists, lactate is overproduced due to increased anaerobic glycolysis, while lactate clearance occurs mostly in the liver (60%), followed by the kidney (30%). The lactate clearance cannot overcome the increased lactate production during the critically ill status. Because liver dysfunction and kidney injury elevate lactate levels due to decreased lactate clearance, we exclude patients with these underlying conditions from our study.

Blood lactate levels can be used as marker for systemic tissue hypoperfusion and disease severity in sepsis: in one large retrospective study from the Netherlands, a 24-h mean lactate \> 2 mmol/L was a strong predictor of intensive care unit (ICU) mortality \[[@R08]\], and the range of lactate values reported in this study were quite similar to the lactate values reported in our study.

Serum lactate concentration is included in the criteria for septic shock defined in Sepsis-3 \[[@R06]\]. Lactate level \> 2 mmol/L (18 mg/dL) after adequate fluid resuscitation and the need for vasopressor therapy in order to maintain mean arterial pressure \> 65 mm Hg characterize septic shock \[[@R06], [@R9]\]. Most published research has focused on lactate level measurements using arterial blood sampling in ED patients with sepsis. However, in the newer definition of septic shock, venous blood lactate levels seem to accurately reflect the abnormal cell-based metabolism and lactate levels can be considered as emerging vital signs \[[@R10]\].

In this prospective observational single center study, we saw a strong, clinically relevant and statistically highly significant correlation between lactate levels measured in the peripheral artery, central and peripheral veins during initial resuscitation in patients with sepsis. These results are in agreement with the findings of a prospective observational study published by Datta et al in 2018, which demonstrated good agreement between arterial lactate and peripheral lactate levels when lactate levels were \> 2 mmol/L in 304 patients with sepsis \[[@R11]\]. Strengths of our study include prospective study design and biologically plausible, highly significant, clinically relevant results. Limitations of our study include the small sample size and the fact that we did not categorize patients based on a specific threshold for lactate concentrations.

Early goal-directed resuscitation protocols used for treatment of patients with sepsis and septic shock aim at reducing mortality \[[@R12]\]. Clinicians often use serial blood lactate level measurements in order to assess disease progression, and arterial puncture samples are most commonly used for lactate level measurement in the blood gas analyzer. However, repeated arterial punctures cause patient discomfort or pain and are associated with small risk of complications, including damage of the artery, bleeding and arterial thrombosis with hand ischemia. Peripheral venous and central venous blood samples can easily be obtained by healthcare professionals with various degrees of skill and experience, have lower risk of complications and sampling is less painful for patients. In cases where placement of a central line is necessary, there are more risks during central line insertion, but fewer disadvantages afterwards.

Based on earlier publications that have demonstrated strong but imperfect agreement between arterial and venous lactate levels \[[@R06]\], use of peripheral vein lactate has been recommended for screening in patients with sepsis \[[@R11]\]. However, we did not identify any publications evaluating the agreement between arterial, venous and central venous lactate levels in patients with sepsis.

In conclusion, based on the strong agreement between venous, arterial and central venous lactate values in our data, it may be reasonable to use peripheral venous or central venous blood samples for measuring lactate levels in order to monitor disease progression and response to therapy in patients with sepsis. However, because this is a small, single center study, additional larger studies are needed to confirm or disprove the validity of our findings.
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